Acinapura A J, Rose D M, Jacobowitz I J, Kramer M D, Robertazzi R R, Feldman J, Zisbrod Z, Cunningham J N
Department of Cardiac Surgery, St. Vincent's Hospital and Medical Center, New York, New York 10011.
Ann Thorac Surg. 1989 Aug;48(2):186-91. doi: 10.1016/0003-4975(89)90065-9.
Internal mammary artery (IMA) bypass grafting to the anterior descending coronary artery was performed in 2,100 patients between January 1978 and July 1986. The average number of additional saphenous vein grafts (SVGs) per patient was 1.8. During the same period, 1,753 patients underwent coronary artery bypass grafting using an SVG (average number of grafts per patient, 3.2). The average patient age was similar: 62.3 years for IMA grafts and 64.7 years for SVGs. Men constituted two thirds of each group. Left ventricular function was impaired (ejection fraction less than 45%) in 1,071 (51%) of IMA grafts and 847 (48.3%) of SVGs. Other aggregate risk factors, ie, elevated blood pressure, diabetes mellitus, previous myocardial infarction, and congestive heart failure, were similar in each group. Operative results and postoperative mortality of the IMA and SVG patients were comparable. However, the long-term probability of cumulative survival and occlusion-free survival were significantly greater and the probability of recurrent angina and reoperative coronary artery bypass grafting were significantly less in IMA graft patients (p less than 0.015). The relative risk of occlusion in an SVG was 4 to 5 times greater than that of the IMA graft. These data indicate that a patent IMA graft to the anterior descending coronary artery protects against recurrent angina and death from cardiac-related causes, and that the IMA should be the conduit of choice.
1978年1月至1986年7月期间,对2100例患者进行了乳内动脉(IMA)至冠状动脉前降支的搭桥手术。每位患者平均额外使用的大隐静脉移植物(SVG)数量为1.8根。在同一时期,1753例患者接受了使用SVG的冠状动脉搭桥手术(每位患者平均移植物数量为3.2根)。两组患者的平均年龄相似:IMA移植患者为62.3岁,SVG移植患者为64.7岁。每组中男性均占三分之二。IMA移植患者中有1071例(51%)、SVG移植患者中有847例(48.3%)存在左心室功能受损(射血分数低于45%)。其他总体危险因素,即高血压、糖尿病、既往心肌梗死和充血性心力衰竭,在每组中相似。IMA和SVG患者的手术结果及术后死亡率相当。然而,IMA移植患者的长期累积生存率和无闭塞生存率显著更高,复发性心绞痛和再次进行冠状动脉搭桥手术的概率显著更低(p<0.015)。SVG闭塞的相对风险比IMA移植高4至5倍。这些数据表明,通畅的IMA移植至冠状动脉前降支可预防复发性心绞痛和心脏相关原因导致的死亡,并且IMA应作为首选的血管 conduit 。 (注:“conduit”这里结合语境大概是“血管通道”之类意思,但原文表述稍显奇怪,可能存在笔误之类情况)